Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Non-Standardized Food Allergenic Extract [EPC]
Echinacea Purpurea Whole is a botanical agent primarily classified as a Non-Standardized Plant Allergenic Extract [EPC]. It is used in clinical settings for allergy diagnosis and immunotherapy, as well as widely utilized in traditional medicine for immune support.
Name
Echinacea Purpurea Whole
Raw Name
ECHINACEA PURPUREA WHOLE
Category
Non-Standardized Food Allergenic Extract [EPC]
Drug Count
29
Variant Count
30
Last Verified
February 17, 2026
About Echinacea Purpurea Whole
Echinacea Purpurea Whole is a botanical agent primarily classified as a Non-Standardized Plant Allergenic Extract [EPC]. It is used in clinical settings for allergy diagnosis and immunotherapy, as well as widely utilized in traditional medicine for immune support.
Detailed information about Echinacea Purpurea Whole
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Echinacea Purpurea Whole.
Echinacea Purpurea Whole refers to the complete biological material derived from the Echinacea purpurea plant, a perennial medicinal herb commonly known as the purple coneflower. In the context of modern clinical pharmacology and the FDA's Established Pharmacologic Class (EPC) system, it is officially categorized as a Non-Standardized Plant Allergenic Extract [EPC]. While the general public often recognizes Echinacea as a dietary supplement used to combat the common cold, its clinical classification as an allergenic extract signifies its use in the diagnosis and treatment of hypersensitivity reactions.
Echinacea Purpurea Whole belongs to a class of drugs called allergenic extracts. These are highly complex biological products derived from environmental sources such as pollens, molds, insect venoms, and plants. Unlike standardized extracts, which have a known and measurable potency (such as Bioequivalent Allergy Units), non-standardized extracts like Echinacea Purpurea Whole are prepared based on weight-to-volume (w/v) ratios or PNU (Protein Nitrogen Unit) concentrations. The FDA has historically regulated these extracts under the Biologics Control Act, ensuring they meet specific purity and identity standards, though their efficacy for specific immunotherapy is often extrapolated from broader botanical and immunological data.
The mechanism of action for Echinacea Purpurea Whole depends entirely on its clinical application. When used as a diagnostic tool (such as in skin prick testing), the extract works by introducing specific plant proteins to the patient's IgE antibodies (Immunoglobulin E) located on the surface of mast cells. If the patient is sensitized to Echinacea purpurea, the cross-linking of these antibodies triggers the release of histamine and other inflammatory mediators, resulting in a visible 'wheal and flare' reaction. This allows healthcare providers to confirm a specific allergy to this plant species.
When used in immunotherapy (allergy shots), the mechanism involves the 'desensitization' of the immune system. Repeated, escalating doses of the extract shift the immune response from a Th2-dominated profile (allergic) to a Th1-dominated profile. This process increases the production of IgG4 'blocking antibodies,' which compete with IgE for the allergen, and promotes the activity of regulatory T-cells (Tregs) that suppress allergic inflammation.
At a molecular level, Echinacea Purpurea contains several bioactive compounds that interact with the human immune system:
As a complex biological extract rather than a single chemical entity, the pharmacokinetics of Echinacea Purpurea Whole are distinct from traditional small-molecule drugs.
Echinacea Purpurea Whole is available in several clinical and commercial forms:
> Important: Only your healthcare provider can determine if Echinacea Purpurea Whole is right for your specific condition. The use of allergenic extracts for immunotherapy must always be conducted under the supervision of a qualified allergist or immunologist.
Dosage for Echinacea Purpurea Whole varies significantly based on whether it is being used for diagnostic testing, immunotherapy, or as a dietary supplement.
For Skin Prick Testing (SPT), a single drop of the 1:10 or 1:20 w/v (weight/volume) extract is applied to the skin, followed by a puncture. For Intradermal Testing, 0.02 mL of a 1:100 or 1:1000 dilution may be injected into the dermis. These procedures must only be performed by medical professionals.
In a clinical setting, the dosage follows a 'build-up' schedule:
While not standardized by the FDA for therapeutic use, common adult doses in clinical literature include:
Pediatric dosing for allergenic extracts is generally the same as adult dosing, as the immune response is not strictly weight-dependent. However, the volume of injections may be adjusted based on the child's tolerance and the clinician's judgment.
No specific dose adjustments are provided for patients with kidney disease. However, since some metabolites are renally cleared, caution is advised in patients with end-stage renal disease (ESRD).
Because Echinacea alkamides are metabolized by the liver (CYP3A4), patients with significant hepatic impairment (Child-Pugh Class B or C) should be monitored closely for signs of toxicity or increased side effects.
Elderly patients should start at the lower end of the dosing spectrum for immunotherapy, as they may have a higher prevalence of underlying cardiovascular disease, which increases the risk of complications if an anaphylactic reaction occurs.
In immunotherapy, a missed dose can disrupt the desensitization process. If a dose is missed by more than one week, the physician may need to reduce the next dose to ensure safety. For oral supplements, skip the missed dose and resume the normal schedule. Never double the dose.
Signs of overdose from oral Echinacea include severe nausea, vomiting, dizziness, and elevated heart rate. In the case of an immunotherapy overdose (injection of too much extract), the primary risk is anaphylactic shock. Symptoms include difficulty breathing, swelling of the throat, rapid pulse, and a sharp drop in blood pressure. This is a medical emergency requiring epinephrine.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Ensure you are using the correct concentration, as allergenic extracts come in various strengths.
When administered as an allergenic extract via injection, the most common side effect is a Local Reaction.
> Warning: Stop taking Echinacea Purpurea Whole and call your doctor immediately if you experience any of these.
Prolonged use (exceeding 8 weeks) of Echinacea Purpurea Whole is generally discouraged. Long-term effects may include:
No FDA black box warnings are currently issued for Echinacea Purpurea Whole as a specific ingredient. However, all allergenic extracts carry a general class warning regarding the risk of severe life-threatening systemic reactions, including anaphylaxis. These products must only be administered in settings equipped with emergency resuscitative equipment and personnel trained in treating anaphylaxis.
Report any unusual symptoms to your healthcare provider. If you experience a large local reaction, your doctor may recommend an over-the-counter antihistamine or an adjustment to your next immunotherapy dose.
Echinacea Purpurea Whole is a potent biological agent that interacts directly with the human immune system. It should never be viewed as a 'simple' herbal remedy when used in clinical concentrations. Patients must be aware that because it is a 'Non-Standardized' extract, the concentration of specific allergens can vary between different manufacturers or even different batches. Always ensure your provider is using a consistent source for immunotherapy.
There are no specific FDA black box warnings for Echinacea Purpurea Whole. However, the FDA requires all allergenic extracts to include a prominent warning that they can cause severe systemic allergic reactions. These reactions can occur even in patients who have previously tolerated the injections without issue.
Echinacea Purpurea Whole generally does not cause sedation. However, if a systemic reaction occurs (dizziness, hypotension), patients should not drive or operate heavy machinery. It is recommended to wait at least one hour after an injection before driving.
Alcohol does not have a direct pharmacological interaction with Echinacea. However, alcohol can cause vasodilation, which might theoretically accelerate the absorption of an injected allergen or mask the early signs of an allergic reaction. Moderate use is generally acceptable, but avoid heavy consumption on the day of an immunotherapy session.
There is no 'withdrawal syndrome' associated with Echinacea. However, stopping immunotherapy prematurely will result in the loss of desensitization, and allergic symptoms will likely return to their baseline levels. If you develop a severe rash or breathing difficulties, discontinue use immediately and consult a physician.
> Important: Discuss all your medical conditions with your healthcare provider before starting Echinacea Purpurea Whole. Provide a full list of all allergies, especially to plants and flowers.
For each major interaction, the management strategy involves either avoiding the combination or performing frequent clinical monitoring. Always inform your doctor of any changes in your medication or supplement regimen.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. This includes over-the-counter cold and flu remedies that may already contain Echinacea.
Patients should be screened for cross-sensitivity if they have reacted to:
A positive reaction to any of these botanicals increases the likelihood of a reaction to Echinacea Purpurea Whole.
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Echinacea Purpurea Whole. Ensure you disclose any history of 'hay fever' or seasonal allergies.
There is a lack of well-controlled clinical trials regarding the use of Echinacea Purpurea Whole in pregnant women. Most experts recommend avoiding the initiation of allergenic extract immunotherapy during pregnancy. If a woman is already on a maintenance dose and becomes pregnant, the physician may choose to continue the therapy at the same dose, but increasing the dose (the 'build-up' phase) is generally avoided due to the risk of anaphylaxis. Anaphylaxis in the mother can lead to uterine contractions and fetal hypoxia (lack of oxygen).
It is unknown whether the complex proteins or alkamides of Echinacea Purpurea Whole pass into human breast milk. Because these are large molecules or rapidly metabolized compounds, the risk to a nursing infant is likely low. However, because of the potential for allergic sensitization in the infant, nursing mothers should consult their pediatrician before using Echinacea supplements or receiving immunotherapy.
Elderly patients (over 65) may have a reduced immune response to immunotherapy. Furthermore, the use of Beta-Blockers (common in the elderly for heart conditions) is a significant concern. Beta-blockers can make anaphylaxis more difficult to treat because they block the effects of epinephrine. A thorough cardiovascular assessment is required for any elderly patient starting Echinacea Purpurea Whole.
No specific studies have been conducted in patients with renal failure. While the proteins in the extract are broken down into amino acids, the alkamides require renal excretion. Use with caution in patients with a GFR (Glomerular Filtration Rate) below 30 mL/min.
Patients with cirrhosis or other forms of hepatic impairment may have reduced clearance of the bioactive components. Based on the Child-Pugh classification, patients with Class B or C impairment should avoid high-dose oral Echinacea due to the risk of metabolic accumulation.
> Important: Special populations require individualized medical assessment. Always inform your specialist if you are planning to become pregnant or have underlying heart or kidney issues.
Echinacea Purpurea Whole acts as an immunomodulator. Its primary molecular targets include:
| Parameter | Value |
|---|---|
| Bioavailability | 40% - 60% (Alkamides) |
| Protein Binding | Significant (Albuim/Alpha-1-acid glycoprotein) |
| Half-life | 1.5 - 3 hours (Major Alkamides) |
| Tmax | 0.5 - 1.5 hours (Oral) |
| Metabolism | Hepatic (CYP3A4, CYP1A2) |
| Excretion | Renal (~60%), Fecal (~30%) |
Echinacea Purpurea Whole is classified as a Non-Standardized Plant Allergenic Extract. It shares this class with other botanical extracts like Ragweed, Oak, and Grass pollens used in clinical immunology. It is also categorized as an Immunostimulant in the context of complementary and alternative medicine (CAM).
Common questions about Echinacea Purpurea Whole
Echinacea Purpurea Whole is primarily used in two ways: clinically as an allergenic extract and traditionally as an immune system support agent. As an allergenic extract, it is used by doctors to diagnose allergies through skin testing and to treat them through immunotherapy (allergy shots). In the supplement world, it is commonly used to help reduce the duration and severity of symptoms associated with the common cold and upper respiratory infections. It is thought to work by stimulating the activity of white blood cells and modulating the body's inflammatory response. However, it is important to note that the FDA does not approve Echinacea for the treatment of specific viral or bacterial infections.
The most common side effects depend on how the medication is administered. When given as an injection for allergy treatment, patients frequently experience local reactions such as redness, itching, and swelling at the site of the shot. If taken orally as a supplement, the most frequent complaints are mild stomach upset, nausea, and a temporary unpleasant taste in the mouth. Some people may also experience a mild headache or dizziness shortly after taking it. While these effects are usually mild, anyone experiencing a widespread rash or difficulty breathing should seek medical attention immediately, as these could be signs of a serious allergic reaction.
There is no known direct chemical interaction between alcohol and Echinacea Purpurea Whole that would cause toxicity. However, healthcare providers generally recommend caution, especially if you are receiving immunotherapy injections. Alcohol can cause your blood vessels to dilate, which might speed up the absorption of an injected allergen and potentially increase the risk of a systemic reaction. Additionally, alcohol can mask early symptoms of an allergic reaction, such as flushing or lightheadedness. It is best to avoid heavy alcohol consumption on the days you receive an allergy treatment or if you are feeling unwell with an infection.
The safety of Echinacea Purpurea Whole during pregnancy has not been definitively established through large-scale clinical trials. Most medical professionals advise against starting new allergy immunotherapy or taking high-dose Echinacea supplements while pregnant. The primary concern is not necessarily the herb itself, but the risk of a severe allergic reaction (anaphylaxis), which could be dangerous for both the mother and the developing fetus. If you are already on a stable maintenance dose of allergy shots, your doctor may allow you to continue, but you should always discuss the risks and benefits with your obstetrician and allergist before proceeding.
The 'onset of action' for Echinacea depends on the intended goal. For allergy diagnostic testing, a reaction on the skin typically appears within 15 to 20 minutes. If you are taking it as a supplement for a cold, clinical studies suggest it is most effective if started at the very first sign of symptoms, with some people noticing a reduction in symptom severity within 24 to 48 hours. However, for those undergoing immunotherapy to desensitize their immune system to allergies, it can take several months of 'build-up' injections before a significant reduction in allergy symptoms is felt, and the full benefit often requires 3 to 5 years of consistent treatment.
Yes, you can generally stop taking oral Echinacea supplements suddenly without experiencing physical withdrawal symptoms. Unlike some medications that require a tapering period, Echinacea does not cause chemical dependency. However, if you are receiving professional allergy immunotherapy, stopping your injections abruptly will cause your immune system to lose its newly acquired tolerance to the allergen. This means your allergy symptoms will likely return to their original severity. If you need to stop your allergy shots for any reason, you should consult your allergist to discuss how this will affect your long-term treatment plan.
If you miss a dose of an oral Echinacea supplement, simply skip the missed dose and take your next dose at the regularly scheduled time; do not take two doses at once to make up for the one you missed. If you miss an appointment for an immunotherapy injection, it is more critical to contact your doctor's office immediately. Because these injections work by gradually increasing your tolerance, missing a dose by more than a week may require your doctor to temporarily reduce your next dose to ensure it is safe. Consistency is key for the success of allergy desensitization therapy.
There is currently no clinical evidence to suggest that Echinacea Purpurea Whole causes weight gain. It does not contain significant calories, nor does it affect the metabolic hormones typically associated with weight changes, such as insulin or cortisol. If you experience sudden weight gain or swelling while taking Echinacea, it is more likely related to an underlying medical condition or a different medication. However, some patients may experience 'angioedema' (swelling under the skin) as part of an allergic reaction, which might feel like sudden puffiness or weight increase, but this is a medical issue rather than a metabolic one.
Echinacea Purpurea Whole can interact with several types of medications, so it is vital to consult your doctor. It is particularly known to interact with drugs that are broken down by the liver's CYP3A4 and CYP1A2 enzymes, such as certain heart medications, anti-anxiety drugs, and even caffeine. Most importantly, because Echinacea stimulates the immune system, it should not be taken with immunosuppressant drugs like cyclosporine or steroids, as it may make them less effective. Always provide your healthcare provider with a complete list of all prescriptions, over-the-counter drugs, and herbal supplements you are currently using.
The concept of 'generic' vs. 'brand name' is slightly different for biological products like Echinacea Purpurea Whole. Because it is a 'Non-Standardized Plant Allergenic Extract,' it is produced by various specialized laboratories (such as Greer or ALK) rather than as a standard generic pill. In the supplement market, it is available from hundreds of different manufacturers under various labels. While the 'whole' plant material is the same species, the concentration and purity can vary significantly between brands. It is always recommended to choose products that have been third-party tested for purity and to stay with the same brand if you are using it for clinical purposes.